Herbal formulation in the treatment of age-related cognitive decline in elderly subjects: A double blind study from India

2000 ◽  
Vol 21 ◽  
pp. 166
Author(s):  
Meera Vaswani ◽  
C. Andrade ◽  
S. Gowda ◽  
S.K. Chakarvorty
2018 ◽  
Vol 21 (5) ◽  
pp. 511-520 ◽  
Author(s):  
Vasu Karlapudi ◽  
Anjaneya Venkata Vara Prasad Mungara ◽  
Krishanu Sengupta ◽  
Barbara A. Davis ◽  
Siba Prasad Raychaudhuri

2017 ◽  
Vol 15 (3) ◽  
pp. 235-241 ◽  
Author(s):  
Jun Takahashi ◽  
Takashi Kanbayashi ◽  
Sachiko Ito Uemura ◽  
Youhei Sagawa ◽  
Kou Tsutsui ◽  
...  

SLEEP ◽  
2017 ◽  
Vol 40 (suppl_1) ◽  
pp. A133-A133
Author(s):  
J Takahahsi ◽  
K Takashi ◽  
S Ito Uemura ◽  
Y Sagawa ◽  
K Tsutsui ◽  
...  

2009 ◽  
Vol 24 (1) ◽  
pp. 61-71 ◽  
Author(s):  
Julia Boyle ◽  
Dennis Wolford ◽  
Cynthia Gargano ◽  
Jacqueline McCrea ◽  
Corinne Cummings ◽  
...  

1997 ◽  
Vol 82 (9) ◽  
pp. 2911-2914
Author(s):  
H. D. Danenberg ◽  
A. Ben-Yehuda ◽  
Z. Zakay-Rones ◽  
D. J. Gross ◽  
G. Friedman

Abstract Background. Dehydroepiandrosterone (DHEA) is a native steroid with an immunomodulating activity that was suggested to counterregulate some phenomena of immunosenescence. Recently, it was shown to reverse the age-associated decline of immune response against influenza vaccine in aged mice. The present study was designed to evaluate the effect of DHEA on the immunization of elderly volunteers against influenza. Methods. Seventy-one elderly volunteers age 61–89 yr were enrolled in a prospective randomized, double-blind study to receive either DHEA (50 mg qd p.o. for four consecutive days starting two days before immunization) or placebo. Antibody response to the vaccine was measured before and 28 days after vaccination. Results. DHEA treatment significantly increased serum DHEA-sulfate (DHEA-S). No enhancement in established immunity was observed. A significant decrease in attainment of protective antibody titer (1:40 or higher) against the A/Texas strain in subjects with nonprotective baseline antibody titer was recorded following DHEA treatment compared with placebo (52% vs. 84%, P < 0.05). Baseline DHEA-S serum levels were inversely related to attainment of immunization in DHEA-treated subjects. Influenza-like morbidity during the winter was low in the study group with no difference between the DHEA and placebo groups. Conclusions. Although highly effective in aged rodents, a short course of DHEA treatment did not improve the age-related declined response to immunization against influenza in human subjects. Higher baseline DHEA-S levels are not predictive of better immunization against influenza in the elderly.


Author(s):  
M. Igase ◽  
Y. Okada ◽  
M. Ochi ◽  
K. Igase ◽  
H. Ochi ◽  
...  

OBJECTIVES: Dementia, which is characterized by a progressive decline in cognitive function, is a major concern in aging societies. Although a number of treatments have been approved, an effective therapy to prevent the disorder is lacking. A supplement that improves cognitive function would benefit patients. The aim of this study was to assess whether auraptene, a citrus coumarin, has a protective effect on cognitive decline. DESIGN: A randomized, placebo-controlled, double-blind study SETTING: Outpatient medical check-up program for cognitive disorders PARTICIPANTS: 84 adult volunteers (they are cognitively normal) met inclusion and exclusion criteria to participate. INTERVENTION: 42 participants received auraptene enriched (containing 6.0 mg/day of auraptene) test juice, and another participants received placebo juice. MEASUREMENTS: 1) Mild Cognitive Impairment (MCI) Screen using the 10-word immediate recall test. 2) The Mini-Mental State Examination (MMSE). Cognitive assessment ware carried out baseline and at 24 weeks. RESULTS: Auraptene enriched test juice did not improve cognitive function after 24 weeks compared with baseline data. However, there was a significant difference in the percentage change in cognitive function between the test and placebo orange juice groups (6.3 ± 18.9 vs. −2.4 ± 14.8, P < 0.05). Multiple regression analysis demonstrated a significant independent relationship between the percentage change in the 10-word immediate recall test score and test juice consumption including baseline 10-word immediate recall test score in all subjects. CONCLUSION: This is the first study to assess the effectiveness of auraptene in the prevention of cognitive decline. Our results suggest that auraptene is a safe supplement for the prevention of cognitive decline.


Sign in / Sign up

Export Citation Format

Share Document